Atlas Trials

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Clinical trial NCT02562508 · COMPLETED

Trial details

NCT number
NCT02562508
Sponsor
Jun Zhang
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial NeoplasiaVulvar Intraepithelial NeoplasiaPersistent Infection
Start date
2015-12-05
Primary completion
2016-08-12
Enrollment
979

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.